| # | Drug | Count |
|---|---|---|
| 0 | RIBOCICLIB | 451 |
| 1 | TRASTUZUMAB | 381 |
| 2 | CAPECITABINE | 373 |
| 3 | CYCLOPHOSPHAMIDE | 359 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 359 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 359 |
| 6 | LETROZOLE | 359 |
| 7 | FULVESTRANT | 355 |
| 8 | BEVACIZUMAB | 327 |
| 9 | CARBOPLATIN | 294 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 722 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 620 |
| 2 | Platinum-based Drug [EPC] | 579 |
| 3 | Aromatase Inhibitor [EPC] | 564 |
| 4 | Corticosteroid [EPC] | 486 |
| 5 | Alkylating Drug [EPC] | 483 |
| 6 | Microtubule Inhibitor [EPC] | 446 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 401 |
| 8 | Estrogen Receptor Antagonist [EPC] | 375 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 334 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 8 | 0.0133 |
| 1 | Estrogen Receptor Antagonist [EPC] | 375 | 0.0092 |
| 2 | Actinomycin [EPC] | 16 | 0.0072 |
| 3 | Lymphocyte Activation Gene-3 Blocker [EPC] | 3 | 0.0058 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 401 | 0.0054 |
| 5 | Aromatase Inhibitor [EPC] | 564 | 0.0050 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 92 | 0.0043 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 66 | 0.0031 |
| 8 | Somatostatin Analog [EPC] | 20 | 0.0029 |
| 9 | Microtubule Inhibitor [EPC] | 446 | 0.0027 |